Hi everyone. It’s Janice Smith Collins, Brilliant Ink’s newest employee. I’m so excited to be here, and equally thrilled to be joining the conversation on our Brilliant Blog.
I’ve spent a number of years working in communications in lots of different industries, especially in technology and also financial services. Considering the mountain of government hearings and discussion about regulation (or not so much) in those arenas, I’m fascinated by the recent FDA hearings on online drug marketing and social media.
In a nutshell, the FDA recently listened to some 70 presentations over the course of two days from a broad range of representatives including a number major pharma companies, online search/content giants Google and Yahoo!, and a bevy of others from industry and public associations, communications and marketing firms, and more. (Now that’s one heck of a PowerPoint deck!)
Here are a few good summaries on what was covered at the hearings:
Or to see a bunch of general buzz and commentary on the topic, check out FDASM.com, self-described as “Everything about the FDA, Internet, and Social Media.”
The FDA will continue to accept public testimony on this topic until February 28, 2010 and then come back with a guideline (though no specific timeline has been set). To see a transcript of the hearings, as well as instructions on how to submit comments on the testimonies, visit the FDA website.
We’ll be interested to see where the FDA lands on this topic. Have thoughts on what the guidelines should include? Let us know in the comments section below…
@janni10
